DBS posts another record quarter, lifting profits and rewarding shareholders with a higher dividend.

Disney surprises Wall Street with strong earnings, while US stocks hover near record highs on hopes of easing geopolitical tensions.

We also examine why Eli Lilly continues to dominate the weight-loss drug market, whether SpaceX investors should stay the course after a disappointing post-IPO performance, and ask if every diversified portfolio should include an oil major as protection against geopolitical shocks.

Plus, a debate over whether AI is creating genuine long-term winners - or the next investment bubble.